A 38-year-old woman from Delhi presents with a 2-month history of jaundice, pruritus, and fatigue. She denies fever, abdominal pain, or recent travel. On examination, she is afebrile, icterus is present, and there is no hepatomegaly or splenomegaly. Laboratory investigations show: total bilirubin 4.5 mg/dL (conjugated 3.2 mg/dL), ALT 68 U/L, AST 72 U/L, ALP 185 U/L, GGT 165 U/L. Serum antimitochondrial antibody (AMA-M2) is positive. Abdominal ultrasound is normal with no bile duct dilation. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Primary Biliary Cholangitis (PBC) ### Key Clinical Features **Key Point:** The combination of **positive AMA-M2 antibody**, insidious jaundice with pruritus, cholestatic LFT pattern, and normal imaging in a middle-aged woman is diagnostic of primary biliary cholangitis. ### Diagnostic Reasoning 1. **Serological Hallmark** - **AMA-M2 positive** = pathognomonic for PBC - AMA-M2 targets pyruvate dehydrogenase complex (PDC-E2) on mitochondria - Present in >95% of PBC cases - This single finding is nearly diagnostic 2. **Clinical Presentation** - **Pruritus** = cardinal symptom of PBC (due to bile salt accumulation) - Insidious onset over months (not acute) - Female, middle-aged (classic demographic: 40–60 years, 9:1 female predominance) - No fever or acute illness 3. **Liver Enzyme Pattern** - ALP (185 U/L) > ALT (68 U/L) — **cholestatic pattern** - But ALT/AST are only mildly elevated, NOT markedly elevated - This is the **intrahepatic cholestasis** pattern of PBC - Conjugated hyperbilirubinemia (3.2/4.5 mg/dL) confirms cholestasis 4. **Imaging Findings** - **Normal ultrasound with no bile duct dilation** is KEY - Rules out extrahepatic obstruction (stones, pancreatic mass, stricture) - PBC is a disease of **small intrahepatic bile ducts** — not visible on ultrasound - MRCP or liver biopsy would show bile duct proliferation and lymphocytic infiltration ### PBC vs. Other Cholestatic Diseases | Feature | PBC | PSC | Viral Hepatitis | Alcoholic Liver Disease | | --- | --- | --- | --- | --- | | **AMA-M2** | Positive (>95%) | Negative | Negative | Negative | | **Pruritus** | Prominent | Mild/absent | Absent | Absent | | **Gender** | Female 9:1 | Male 2:1 | Any | Male predominance | | **Bile duct dilation** | No (small ducts) | Yes (large ducts) | No | No | | **Imaging** | Normal or cirrhosis | Beading, strictures | Normal | Steatosis, cirrhosis | | **Onset** | Insidious | Insidious | Acute | Variable | | **Associated autoimmune** | Yes (Sjögren, RA) | IBD (70%) | No | No | **High-Yield:** **AMA-M2 positive + pruritus + cholestasis + normal imaging = PBC**. This is the most tested PBC scenario in NEET PG. ### Pathophysiology of Pruritus in PBC ```mermaid flowchart TD A[Autoimmune destruction of small bile ducts]:::outcome --> B[Impaired bile acid excretion] B --> C[Bile acid accumulation in serum] C --> D[Activation of TGR5 and FXR on sensory nerves] D --> E[Pruritus]:::outcome B --> F[Cholestasis] F --> G[Conjugated hyperbilirubinemia]:::outcome ``` ### Staging of PBC (Ludwig Classification) - **Stage I:** Portal inflammation, bile duct injury - **Stage II:** Portal fibrosis, bile duct proliferation - **Stage III:** Septal fibrosis - **Stage IV:** Cirrhosis **Clinical Pearl:** Patients with PBC often have associated autoimmune conditions (Sjögren syndrome in 70%, rheumatoid arthritis, thyroiditis). Always screen for these. [cite:Harrison 21e Ch 294]